Home

Schlichter Vorarbeiter Donner spike protein receptor binding domain Traurig Glauben Frank

Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor | Nature Communications
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor | Nature Communications

SARS-CoV-2 spike protein fusion transformation - Proteopedia, life in 3D
SARS-CoV-2 spike protein fusion transformation - Proteopedia, life in 3D

Dynamics of the interaction between the receptor-binding domain of SARS-CoV-2 Omicron (B.1.1.529) variant and human angiotensin-converting enzyme 2 [PeerJ]
Dynamics of the interaction between the receptor-binding domain of SARS-CoV-2 Omicron (B.1.1.529) variant and human angiotensin-converting enzyme 2 [PeerJ]

Extensive Range of SARS-CoV-2 Reagents Available
Extensive Range of SARS-CoV-2 Reagents Available

The receptor binding domain of the SARS-CoV-2
The receptor binding domain of the SARS-CoV-2

NIH Scientists Identify Atomic Structure of Novel Coronavirus Protein | NIAID: National Institute of Allergy and Infectious Diseases
NIH Scientists Identify Atomic Structure of Novel Coronavirus Protein | NIAID: National Institute of Allergy and Infectious Diseases

RBD targeted COVID vaccine and full length spike-protein vaccine (mutation and glycosylation role) relationship with procoagulant effect
RBD targeted COVID vaccine and full length spike-protein vaccine (mutation and glycosylation role) relationship with procoagulant effect

Frontiers | Antibodies and Vaccines Target RBD of SARS-CoV-2
Frontiers | Antibodies and Vaccines Target RBD of SARS-CoV-2

Human Antibodies Target Many Parts of Coronavirus Spike Protein – NIH Director's Blog
Human Antibodies Target Many Parts of Coronavirus Spike Protein – NIH Director's Blog

The structural basis of accelerated host cell entry by SARS‐CoV‐2† - Seyran - 2021 - The FEBS Journal - Wiley Online Library
The structural basis of accelerated host cell entry by SARS‐CoV‐2† - Seyran - 2021 - The FEBS Journal - Wiley Online Library

Key residues of the receptor binding domain in the spike protein of SARS-CoV-2 mediating the interactions with ACE2: a molecular dynamics study - Nanoscale (RSC Publishing)
Key residues of the receptor binding domain in the spike protein of SARS-CoV-2 mediating the interactions with ACE2: a molecular dynamics study - Nanoscale (RSC Publishing)

SARS-CoV-2 IgG antibodies and why the receptor-binding domain of the spike protein is so important - YouTube
SARS-CoV-2 IgG antibodies and why the receptor-binding domain of the spike protein is so important - YouTube

Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity - Computational and Structural Biotechnology Journal
Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity - Computational and Structural Biotechnology Journal

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor | Nature
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor | Nature

Structural Characterization of N‐Linked Glycans in the Receptor Binding Domain of the SARS‐CoV‐2 Spike Protein and their Interactions with Human Lectins - Lenza - 2020 - Angewandte Chemie International Edition - Wiley Online Library
Structural Characterization of N‐Linked Glycans in the Receptor Binding Domain of the SARS‐CoV‐2 Spike Protein and their Interactions with Human Lectins - Lenza - 2020 - Angewandte Chemie International Edition - Wiley Online Library

Cell entry mechanisms of SARS-CoV-2 | PNAS
Cell entry mechanisms of SARS-CoV-2 | PNAS

The antigenic anatomy of SARS-CoV-2 receptor binding domain - Instruct-ERIC
The antigenic anatomy of SARS-CoV-2 receptor binding domain - Instruct-ERIC

Monoclonal antibody designed for SARS-nCoV-2 spike protein of receptor binding domain on antigenic targeted epitopes for inhibition to prevent viral entry | Molecular Diversity
Monoclonal antibody designed for SARS-nCoV-2 spike protein of receptor binding domain on antigenic targeted epitopes for inhibition to prevent viral entry | Molecular Diversity

Targeting SARS-CoV-2 Receptor Binding Domain with Stapled Peptides: An In Silico Study | The Journal of Physical Chemistry B
Targeting SARS-CoV-2 Receptor Binding Domain with Stapled Peptides: An In Silico Study | The Journal of Physical Chemistry B

Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods | Journal of Biosciences
Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods | Journal of Biosciences

Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2 - ScienceDirect
Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2 - ScienceDirect

Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains - ScienceDirect
Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains - ScienceDirect

PDB-101: Molecule of the Month: SARS-CoV-2 Spike
PDB-101: Molecule of the Month: SARS-CoV-2 Spike

The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein | eLife
The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein | eLife

Do Structures Of The Coronavirus Spike Protein Hold The Key To Winning? | Peak Proteins
Do Structures Of The Coronavirus Spike Protein Hold The Key To Winning? | Peak Proteins

a) Structure of the receptor-binding domain (RBD) of the S protein in... | Download Scientific Diagram
a) Structure of the receptor-binding domain (RBD) of the S protein in... | Download Scientific Diagram

In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations | mSystems
In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations | mSystems